Colin Barker, M.D., specializes in interventional and geriatric cardiology including the effects of polypharmacy (multiple medications and their interactions). His research includes a clinical trial at the Memorial Hermann Heart & Vascular Institute evaluating angioplasty through the wrist artery and a study on a genetic marker for stent patients who are resistant to blood thinners.
Previous Interview: http://bit.ly/rqA9dz
Anne Dougherty, M.D., is a cardiac electrophysiologist whose clinical interests include cardiac pacing, defibrillation and ablation of cardiac arrhythmias. Her research includes preventing early cardiac death with an automatic defibrillator vest and cardiovascular effects of cocaine.
Francisco Fuentes, M.D., specializes in general cardiology, preventive cardiology, echocardiography and invasive cardiovascular medicine. He founded and has conducted the annual Preventative Cardiology Forum, one of the most comprehensive courses in preventive cardiology, for more than 20 years. Currently he is investigating how to optimize medical and surgical therapies for patients with coronary artery disease and type 2 diabetes. Fuentes is also a recognized community health educator and routinely volunteers at the San Jose Clinic.
Previous interview: http://go.uth.edu/fuentes
John P. Higgins, M.D., specializes in non-invasive cardiology including nuclear cardiology, echocardiography and positron emission tomography, as well as exercise physiology and sports medicine. He has researched the effects of sports and energy beverages on the body and has led research on a program to detect heart problems in children and prevent sudden cardiac arrest, particularly in athletes.
Stefano Sdringola, M.D., specializes in primary and secondary prevention of coronary heart disease. He is principal investigator of the Century Health Study, a five-year clinical research study looking at lifestyle factors, preventive health teaching and advanced heart imaging for treating and preventing coronary heart disease. The study is being conducted in collaboration with Memorial Hermann-Texas Medical Center.
Previous Interview: http://www.youtube.com/watch?v=dcx_3nclXZ8
Richard Smalling, M.D., Ph.D., is a national leader in coronary artery angiography and revascularization and percutaneous treatment of adult congenital heart disease and valvular heart disease. He also has significant expertise in treatment of peripheral vascular disease including carotid stenting; percutaneous endovascular repair of abdominal aortic aneurysm; and renal, iliac, femoral and below-knee angioplasty and stenting. His research includes the pre-hospital use of clot busters by emergency care teams in the field. He holds several patents and has formed a company, Windmill Cardiovascular Systems, to produce a new implantable left ventricular assist device.
Previous Interview: http://bit.ly/bjyAqR